Partners News Thirona closes financing round
2 November 2021

Radboudumc spin-off Thirona just closed a financing round with Belgian investment fund HERAN Partners, and Borski Fund from the Netherlands. The proceeds of the financing round will be allocated to accelerate the company’s transition towards market leadership in medical imaging.

Now that Thirona is closing in on 10 million images analyzed and Thirona’s solutions have been validated in over 180 scientific publications, they are looking to expand operations and scale up development efforts. As a company, Thirona has always placed a high emphasis on research and development. This has enabled them to establish strong academic, clinical, and industrial partnerships. Now, Thirona find themselves at a tipping point in their journey, expediting their international expansion and development goals. They are pleased to have found the right partners in HERAN Partners and Borski Fund to help accelerate their growth trajectory.

Read more in Thirona's press release

Related news items

Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm

4 April 2022

Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides.

read more

Successful Investment Day at Radboudumc Knowledge valorization as fourth core task in UMCs

7 October 2021

On September 28th, Radboudumc, Briskr, and Oost NL organized an Investment Day for the first time.

read more

Meet BabyChecker!

24 September 2021

On September 20th, 2021, Delft Imaging launched BabyChecker: an affordable and portable smartphone-based ultrasound solution.

read more

ScreenPoint Medical raises $28 million for further development Series C funding led by Insight Partners

2 August 2021

ScreenPoint Medical has raised $28 million in a Series C financing. ScreenPoint Medical is a spin-off of the Radboudumc.

read more

How Thirona shows the impact of AI on society

23 April 2021

This is how 'the best marketing stunt ever' kick-started Thirona's ambitions.

read more